You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice

Citation Tools

Article menu

Download PDFPDF

Scientific Abstracts
Publication Only
Scleroderma, myositis and related syndromes
AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Koneva O, Garzanova L, Glukhova S, et al
AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice
Annals of the Rheumatic Diseases 2022;81:1491.